Amended Statement of Beneficial Ownership (3/a)
April 29 2021 - 05:56PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Deutsch Corey |
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/3/2021
|
3. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [LFMD]
|
(Last)
(First)
(Middle)
C/O LIFEMD, INC.,, 800 THIRD AVENUE, SUITE 2800 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Chief Business Officer / |
(Street)
NEW YORK,, NY 10022
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY) 2/5/2021
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 48630 (1)(2) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Options to purchase shares of Common Stock (3) | (4) | (4) | Common Stock, par value $0.001 | 25000 | (4) | D (4) | |
Options to purchase shares of Common Stock | (5) | (5) | Common Stock, par value $0.001 | 175000 | (5) | D (5) | |
Explanation of Responses: |
(1) | This Form 3 amendment is being filed to correct the number of shares directly owned Mr. Deutsch as of February 3, 2021. |
(2) | Previously filed Form 3/A on April 29, 2021 was erroneously filed with a scriveners error related to the date Mr. Deutsch purchased such shares. The shares were purchased by Mr. Deutsch on November 19, 2020, in a private placement offering by the Company. |
(3) | On February 3, 2021 (the "Effective Date"), Mr. Deutsch and the Issuer entered into First Amendment to Employment Agreement (the "Amended Employment Agreement"), whereby Mr. Deutsch was appointed Chief Business Officer of the Issuer. As of the Effective Date, the Board of Directors of the Issuer has acknowledged the role of Chief Business Officer as an executive officer position. |
(4) | Pursuant to the terms of the consulting agreement, by and between Mr. Deutsch and the Issuer, dated December 3, 2020, Mr. Deutsch was granted stock options to purchase up to 25,000 shares of the Company's common stock at an exercise price of $8.25 per share (the "Consultancy Stock Options"). The Consultancy Stock Options vested on December 3, 2020. |
(5) | Pursuant to the terms of the employment agreement, by and between Mr. Deutsch and the Issuer, dated January 14, 2021, Mr. Deutsch was granted stock options to purchase up to 175,000 shares of the Company's common stock at an exercise price of $7.07 per share (the "Stock Options"). The Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 36 months, beginning on the Effective Date. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Deutsch Corey C/O LIFEMD, INC., 800 THIRD AVENUE, SUITE 2800 NEW YORK,, NY 10022 |
|
| Chief Business Officer |
|
Signatures
|
/s/ Corey Deutsch | | 4/29/2021 |
**Signature of Reporting Person | Date |
Conversion Labs (NASDAQ:CVLB)
Historical Stock Chart
From Feb 2024 to Mar 2024
Conversion Labs (NASDAQ:CVLB)
Historical Stock Chart
From Mar 2023 to Mar 2024